Evidence map›Paper›PMID 42802265›Full record

ArticleTropical medicine and health2026

The rising burden of scabies in Italy: insights from a nationwide survey of dermatologists.

Luca Fania, Antonio Di Guardo, Elena Mari, Francesco Moro, Giovanni Di Lella, Laura Colonna, Francesco Ricci, Alessandra Latini, Saturnino Gasparini, Gian Luigi Giovene and 4 more

Abstract read
In one paragraph

Article in Tropical medicine and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Luca Fania *Dermatological Research Hospital, IDI-IRCCS, 00167, Rome, Italy.
Antonio Di Guardo *Dermatological Research Hospital, IDI-IRCCS, 00167, Rome, Italy.
Elena MariAzienda Sanitaria Locale Roma 1 (ASL RM1), 00195, Rome, Italy.
Francesco MoroDermatological Research Hospital, IDI-IRCCS, 00167, Rome, Italy. f.moro@idi.it.
Giovanni Di LellaDermatological Research Hospital, IDI-IRCCS, 00167, Rome, Italy.
Laura ColonnaDermatological Research Hospital, IDI-IRCCS, 00167, Rome, Italy.
Francesco RicciDermatological Research Hospital, IDI-IRCCS, 00167, Rome, Italy.
Alessandra LatiniSTI/HIV Unit, San Gallicano Dermatological Institute IRCCS, 00144, Rome, Italy.
Saturnino GaspariniSkin - Centro Gasparini, 05100, Terni, Italy.
Gian Luigi GioveneCentro Direzionale Genna, 06124, Perugia, Italy.
Domenico PiccoloNovea Skin Center, 67100, L'Aquila, Italy.
Davide MelandriDermatologic Unit and Burn Center, AUSL Romagna, "M. Bufalini" Hospital, 47521, Cesena, Italy.
Fabio ArcangeliDepartment of Dermatology, Guglielmo Marconi University, 00193, Rome, Italy.
Cesare MassoneDermatology Unit, E.O. Ospedali Galliera, 16128, Genoa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundScabies is an increasingly relevant dermatological and public health issue, with rising case burdens reported in several European countries.

objectivesTo assess Italian dermatologists' perceptions of recent scabies trends and current approaches to diagnosis, treatment, notification, and household-contact management.

methodsA nationwide cross-sectional online survey was distributed to dermatologists practicing in Italy. The questionnaire investigated perceived epidemiological changes, diagnostic and notification practices, therapeutic choices, ivermectin use, retreatment, household-contact management, and perceived treatment failure. Descriptive, bivariate, and multivariable analyses were performed.

resultsAmong 308 respondents, 94.2% perceived an increase in scabies cases during the previous 3-5 years, including 73.4% reporting a marked increase; 59.4% indicated that the increase involved all age groups. Clinical evaluation combined with dermoscopy was the most frequently reported diagnostic approach (88.0%), while 79.2% considered diagnosis often delayed. Combined topical and systemic therapy was the most commonly reported first-line approach (56.5%), and 81.8% perceived treatment failures, particularly with topical permethrin, as more frequent than in the past. Among the 306 respondents providing data on household-contact management, 83.3% reported systematically treating cohabitants. Significant differences emerged according to geographical area and workplace setting. In adjusted analyses, private practitioners were less likely to report systematic treatment of household contacts, whereas longer professional experience was associated with greater perception of increasing treatment failure.

conclusionsItalian dermatologists perceive scabies as an increasingly frequent and clinically challenging condition. These findings support standardized management pathways integrating dermatologists, general practitioners, and public health services, with coordinated household-contact treatment and careful assessment of adherence and reinfestation before therapeutic escalation or attribution of perceived failure to resistance. Objective epidemiological and treatment-outcome studies remain necessary.

Indexed as

EctoparasitosisIvermectinPermethrinPublic healthScabiesTherapeutic failure

Identifiers

PMID42802265
PMCPMC13617695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.